Viral hepatitis in the Arctic

References

• McMahon BJ, Shapiro C, Robertson B. Hepatitis A Virus. In Haubrich W, Schaffner F, Berk JE. Bockus Gastroenterology 5th Edition.VV.B. Saunders Company, Philadelphia, 1995: 2044–2061.
   Google Scholar
• Skinhoj p McNair A, Anderson ST Hepatitis and hepatitis B-antigen in Greenland. Am J Epidemiol 1974; 99: 50–57.
   Google Scholar
• Langer BCA, Frosner GG, von Brunn A. Epidemiolo-gical study of viral hepatitis types A, B, C, D and E in West Greenland. J Viral Hepatitis 1997; 4: 339–349.
   PubMed Web of Science ®Google Scholar
• Minuk GY, Nicolle LE, Postl B,Waggoner JG, Hoofnagle JH. Hepatitis virus infection in an isolated Canadian Inuit (Eskimo) population. J. Med Virol 1982; 10: 255–264.
   PubMed Web of Science ®Google Scholar
• Netesova IG, laroslavtseva OA, Dryga SA, Posukh OL Osipova LP, Bronshtein EL, Zaitsev SA, Netesov SV. Frequency of encountering markers of viral hepatitis A, B, and C, in the aboriginal inhabitants of northwest region of Siberia [Russian, English abstract]. Voprosy Virusologii 1995; 40: 172–4.
   Google Scholar
• Trotsenko OE, Bogach VV, Karepina MV, luzhakov LI. The prevalence of etiological forms of viral hepatitis in Khabarovsk. [Russian, English abstract]. Whurnal Mikrobiologii, Epidemiologii 1 Immunobiologii 1994; 4: 35–8.
   Google Scholar
• Peach D, McMahon B, Bulkow L, Funk B, Harpaz R, Margolis HS. Impact of recurrent epidemics of hepatitis A virus infection on population immunity levels: Bristol Bay, Alaska. J Infectious Dis 2002; 186: 1081–1085.
   Web of Science ®Google Scholar
• McMahon BJ, Beller M, Williams J, Schloss M, Tantila H, Bulkow L.A program to control an outbreak of hepa titis A in Alaska by using an inactivated hepatitis vaccine. Arch Pediat Adolescent Med 1996; 150: 733–739.
   Google Scholar
• an Damme P, Banatvala J, Fay O, lwarson S, McMahon B, Van Herck K, Shouval D, Bonanni P, Connor B, Cooksley B, Leroux-Roels G, Von Sonnenburg F, the International Consensus Group on Hepatitis AVirus Immunity. Consensus Statement Hepatitis A booster vaccination: is there a need? Lancet 2003; 362: 1065–71.
   Google Scholar
• Lok ASF, McMahon BJ. American Association for theStudy of Liver Disease Practice Guideline: Chronic Hepatitis B. Hepatology 2001:34;1225–1241.
   PubMed Web of Science ®Google Scholar
• Skinhoj R Hepatitis and hepatitis B-antigen in Greenland. II: Occurrence and interrelation of hepatitis B associated surface, core, and “e” antigen-antibody systems in a highly endemic area. J Epidemiol 1977; 105: 99–106.
   Web of Science ®Google Scholar
• Olsen OR, Skinhoj P, Krogsgaard K, Baik L. Hepatitis B—an endemic sexually transmitted infection in a local community in Greenland [Danish, English abstract] Ugeskrift for Laeger. 1989; 151: 1668–70.
   Google Scholar
• Anonymous. Hepatitis B infection in Canada. Can Med Assoc J 1985; 132: 817–8.
   Google Scholar
• Minuk GY, Ling N, Postl B,Waggoner JG, Nicolle LE, Hoofnagle JH. The changing epidemiology of hepatitis B virus infection in the Canadian North. Am J Epidemiol 1985; 121: 598–604.
   PubMed Web of Science ®Google Scholar
• Larke RPB, Froese GJ, Devine RDO, Petruk MW. Extension of the epidemiology of hepatitis B in Circumpolar Regions through a comprehensive sero-logic study in the Northwest Territories of Canada. J Med Virol 1987; 22: 269–276.
   Web of Science ®Google Scholar
• Baikie M, Ratnam S, Bryant DG, Jong M, Bokhout M. Epidemiologic features of hepatitis B virus infection in northern Labrador. Can Med Assoc J 1989; 141: 191–5.
   Web of Science ®Google Scholar
• Ohba K, Mizokami M, Kato, et al. Seroprevalence of hepatitis B virus, hepatitis C virus and GB virus-C infections in Siberia. Epidemiol Infect 1999; 122: I 39–44.
   Web of Science ®Google Scholar
• Netesova IG, Swenson PD, Osipova LP, et al. Hepatitis B markers in southern Altai inhabitants of the village of Mendur-Sokkon (the Republic of Altai). HBsAg subtyping in hepatitis B isolates with monoclonal antibodies (Russian). Lhurnal Mikrobiologii, Epidemiologii 1 lmmunobiologii 2001; 2: 29–33.
   Google Scholar
• Reshetnikov OV, Khryanin AA,Teinina TR, Krivenchuk NA, Zimina IU. Hepatitis B and C seroprevalence in Novosibirsk, western Siberia. Sex Transm Dis 2001; 77: 463.
   Google Scholar
• Mikhailov MI, Gomberg MA, Dolzhanskaya NA, Kou-banova AA. Significance of sexual route of transmission of hepatitis B and C in Russia. lnternat J STD Aids. 2002: 13(Suppl 2):9–11.
   Google Scholar
• Beutels P, Shkedy Z, Mukomolov S,Aerts M, Shargo-godskaya E, Plotnikova V, Molenberghs G,Van Damme P. Hepatitis B in St Petersburg, Russia (1994–1999): incidence, prevalence and force of infection. J Viral Hepatitis 2003; 10: 141–9.
   Web of Science ®Google Scholar
• Schreeder MT, Bender TR, McMahon BJ, Moser MR, Murphy BL, Sheller MJ, Heyward WL, Hall DB, and Maynard JE. Prevalence of hepatitis B in selected Alaskan Eskimo villages. Am J Epidemiol, 1983; 118: 543–549.
   PubMed Web of Science ®Google Scholar
• McMahon, BJ, Alward WLM, Hall DB, Heyward WL, Bender TR, Francis DP, Maynard JE.Acute hepatitis B infection: relationship of age to the clinical expression of disease and the subsequent development of the carrier state. J Infect Dis 1985; 151: 599–603.
   PubMed Web of Science ®Google Scholar
• McMahon BJ, Rhoades ER, Heyward WL, Tower E, Ritter D, Lanier AP,Wainwright RB, Helminiak C. A comprehensive programme to reduce the incidence of hepatitis B virus infection and its sequelae in Alaskan Natives. Lancet 1987;ii:1134–1136.
   Google Scholar
• Harpaz R, McMahon BJ, Margolis HS, Shapiro CN, Havron D, Carpenter G, Bulkow L,Wainwright RB. Elimination of new chronic hepatitis B virus infections: results of the Alaska immunization program. J Infect Dis 2000; 181: 413–418.
   PubMed Web of Science ®Google Scholar
• Mahoney FJ,Woodruff BA, Erben JJ, Coleman PJ, Reid EC, Schatz GC, Kane MA. Effect of a hepatitis B vaccination program on the prevalence of hepatitis B virus infection. J Infect Dis 1993; 167: 203–7.
   PubMed Web of Science ®Google Scholar
• Chang MH, Chen CJ, Lai MS et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepato-cellular carcinoma in children. N Engl J Med 1997; 336: 1855–1859.
   PubMed Web of Science ®Google Scholar
• Lavanchy D, McMahon B. Worldwide prevalence and prevention of hepatitis C. In Liang TJ, Hoofnagle JH, (eds). Hepatitis C. Academic Press. San Diego. 2000: 185-202.
   Google Scholar
• Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Goa F, Moyer LA, Kaslow RA, Margolis HS.The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999; 341: 556–562.
   PubMed Web of Science ®Google Scholar
• McMahon BJ, Christensen C,Gretch DR, Bruden DA, Deubner H, Sullivan D, Williams J, Hennessey T. Hepatitis C (HCV) population-based long-term outcomes study in Alaska Natives: risk factors associated with HCV infection. Hepatology 2000; 32: 367A.
   Google Scholar
• Lvov DK, Samokhvalov El, Tsuda F. Prevalence of hepatitis C virus and distribution of its genotypes in northern Eurasia. Arch Virol 1996; 141: 1613–22.
   Google Scholar
• Hadziyannis SJ. Hepatitis D. Clin Liver Dis 1999; 3: 309–325.
   Google Scholar
• Ratnam S, Head CB, Butler RW. Lack of evidence of hepatitis D (delta) infection in Newfoundland and Labrador. Can Med Assoc J 1986; 134: 905–7.
   Web of Science ®Google Scholar
• Krawczynski K. Hepatitis E. Hepatology 1993; 17: 932–41.
   Google Scholar
• Mast EE, Kuramoto K, Favorov MO, Schoening VR, Burkholder BT, Shapiro CN, Holland PV. Prevalence of and risk factors for antibody to hepatitis E virus seroreactivity among blood donors in northern California. J Infect Dis 1997; 176: 34–40.
   Web of Science ®Google Scholar
• McMahon BJ. Hepatocellular Carcinoma and Viral Hepatitis. In: Wilson, RA (ed),Viral Hepatitis. Marcel Dekker, Inc., NewYork. 1997: pp 315-330.
   Google Scholar
• Shikhoj P, Hansen JPH, Nielson BH, Mikkelsen F. Occurrence of cirrhosis and primary liver cancer in an Eskimo population hyperendemically infected with hepatitis B virus.Am J Epidemiol 1978; 108: 121–25.
   Web of Science ®Google Scholar
• Melbye M, Shikhoj P, Nielson BH, Vestergaard BF, Ebbesen P, Hansen JPH, Biggar RJ. Virus-associated cancers in Greenland: frequent hepatitis B virus infection but low primary hepatocellular carcinoma incidence. J Nat Cancer lnstit 1984; 73: 1267–72.
   PubMed Web of Science ®Google Scholar
• Storm HH, Nielson NH. Cancer of the digestive system in circumpolar Inuit.Acta Oncologica 1996; 35: 553–70.
   PubMed Web of Science ®Google Scholar
• McMahon BJ, Hoick P. Bulkow L, Snowball M. Serologic and clinical outcomes of 1536 Alaska Natives chronically infected with hepatitis B virus.Ann Intern Med 2001; 135: 759–768.
   PubMed Web of Science ®Google Scholar
• McMahon BJ, Bulkow L, Harpster A, Snowball M, Lanier A, Sacco F, Dunaway E,Williams J. Screening for hepa-tocellular carcinoma in Alaska Natives infected with chronic hepatitis B: a 16-year population-based study. Hepatology 2000; 32: 842–846.
   PubMed Web of Science ®Google Scholar
• The European Association for the Study of the Liver (EASL) Jury. EASL International Consensus Conference on Hepatitis B. J Hepatology 2003; 38: 533–40.
   Google Scholar
• Core Working Party for Asian Pacific Consensus on Hepatitis B and C. Consensus statements on the pre-vention and management of hepatitis B and C in the Asia-Pacific region. J Gastro Hepatol 2000; 15: 825–41.
   Google Scholar
• Canadian Association for the Study of the Liver. Canadian Consensus Conference on the Management of Viral Hepatitis. Can J Gastroenterol 2000; 15: Supp:5B–20B
   Google Scholar